NCT06168318 - A Study to Investigate the Relative Bioavailability and Food Effect of an Oral Capsid Inhibitor Tablet Formulation Compared With Other Oral Tablet Formulations in Male and Female Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 18, 2023

Primary Completion Date

June 3, 2024

Study Completion Date

June 3, 2024

Conditions

HIV Infections

Interventions

DRUG

VH4004280 Formulation A

Oral administration of VH4004280 Formulation A in fasted or fed conditions.

DRUG

VH4004280 Formulation B

Oral administration of VH4004280 Formulation B in fasted or fed conditions.

DRUG

VH4004280 Formulation C

Oral administration of VH4004280 Formulation C in fasted or fed conditions.

DRUG

VH4004280 Formulation D

Oral administration of VH4004280 Formulation D in fasted or fed conditions.

DRUG

VH4004280 Formulation E

Oral administration of VH4004280 Formulation E in fasted or fed conditions.

Trial Locations (1)

GSK Investigational Site, Nottingham